questionText: To ask the Secretary of State for Health and Social Care, whether he plans to issue guidance to NHS England on the provision of additional cervical and vaginal cancer surveillance for women exposed in utero to diethylstilbestrol (DES), beyond HPV primary screening, where clinically indicated.
answerText: I apologise unreservedly and express my sincere sympathy to all those affected by exposure to diethylstilbestrol (DES), including those exposed in utero and their families. National Health Service records are held by individual NHS organisations and gener...
heading: Diethylstilbestrol: Side Effects